Probably, the cellular immune response may help towards the antiviral activity and could raise the nitric oxide (NO) production by A549 cells, a product of iNOS function, described to be effective in reducing SARS-CoV-2 replication in patients with COVID-19 [71,72]. The gene discussed is NOS2; the disease is COVID-19.